| Name | Title | Contact Details |
|---|
Sensiotec Inc., a medical device company, designs and delivers non-contact remote vital signs monitoring solutions in the United States. The company offers Virtual Medical Assistant that monitors patients, supporting evidenced-based medicine; and monitors heart and respiration rates and movement without pressure pads, sensors, or cuffs that touch the patient. The company serves acute and subacute care facilities, which include hospitals, surgery centers, outpatient clinics, skilled nursing, long-term care and hospice facilities. Sensiotec Inc. was founded in 2008 and is based in Atlanta, Georgia.
Sorenson BioScience is a manufacturer of disposable plastic liquid handling products. Located in Salt Lake City, Utah, it was founded in 1981 as Mµlti Technology, Inc. The company rapidly became an innovator in the manufacture of liquid handling products
Accusync Medical Research Corp is a Milford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Franklin Dental Supply Inc is a Garden City, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
InfraScan, Inc. is a medical device company that focuses on developing, commercializing, and distributing hand-held diagnostic devices for head injury and stroke assessment based on near infrared (NIR) technology. The Infrascanner enables clinicians to detect effectively, conveniently, and accurately intracranial bleeding in patients with head trauma. Intracranial hematomas are an important treatable cause of secondary brain injury in patients with head trauma. Recent statistics from Iraq shows that 30% of all wounded in action have head injuries; of them 40% have brain hematomas. Dr. Britton Chance (University of Pennsylvania) and Dr. Claudia Robertson (Baylor College of Medicine) invented a NIR system for detection of brain Hematomas and tested it successfully in 305 patients in Baylor. An entrepreneurial team formed a company around this technology in Collaboration with Drexel University and won the Wharton Business Plan competition in April 2004 and the second prize at the global business plan competition in Singapore in October 2004. Office of Naval Research funded the company in May 2004. The company also attracted $1.5M in funding from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, from Ben Franklin Technology Partners of Southeastern Pennsylvania, and from Philadelphia Industrial Development Corporation. A multicenter clinical study to support an FDA submission started in July 2006, and on February 2008 an application was submitted to the FDA. After 4 years of review, the FDA cleared Infrascanner Model 1000 as a DeNovo medical technology in December 2011. In January 2013 the FDA cleared the 510(k) of Infrascanner Model 2000.